Get started

FightMND

Alternate names: Fight MND, F I G H T M N D
Country: AU
ROR: 02htmqw41
Crossref ID: 100014012
DOI: 10.13039/100014012
OpenAlex ID: F4320314730
TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS
2020 · Chien-Hsiung Yu, Sophia Davidson, et al. · Cell · 1,050
PDF
Superoxide Dismutase 1 in Health and Disease: How a Frontline Antioxidant Becomes Neurotoxic
2020 · Benjamin G. Trist, James B. Hilton, et al. · Angewandte Chemie International Edition · 246
PDF
Motor Neuron Susceptibility in ALS/FTD
2019 · Audrey M. G. Ragagnin, Sina Shadfar, et al. · Frontiers in Neuroscience · 235
PDF
Ferroptosis mediates selective motor neuron death in amyotrophic lateral sclerosis
2021 · Taide Wang, Doris Tomas, et al. · Cell Death and Differentiation · 199
PDF
Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer’s disease
2020 · Sanka Amadoru, Vincent Doré, et al. · Alzheimer s Research & Therapy · 197
PDF
CuII(atsm) inhibits ferroptosis: Implications for treatment of neurodegenerative disease
2019 · Adam Southon, Kathryn Szostak, et al. · British Journal of Pharmacology · 144
PDF
CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
2021 · Tesfaye Wolde Tefera, Frederik J. Steyn, et al. · Cell & Bioscience · 124
PDF
Skeletal muscle in amyotrophic lateral sclerosis
2023 · Jeremy M Shefner, Antonio Musaro, et al. · Brain · 120
PDF
Early onset diagnosis in Alzheimer’s disease patients via amyloid-β oligomers-sensing probe in cerebrospinal fluid
2024 · Jusung An, Kyeonghwan Kim, et al. · Nature Communications · 119
PDF
ALS monocyte-derived microglia-like cells reveal cytoplasmic TDP-43 accumulation, DNA damage, and cell-specific impairment of phagocytosis associated with disease progression
2022 · Hazel Quek, Carla Cuní-López, et al. · Journal of Neuroinflammation · 110
PDF
Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS
2022 · Paul J. Hop, Ramona A.J. Zwamborn, et al. · Science Translational Medicine · 110
PDF
Amyotrophic Lateral Sclerosis and Autophagy: Dysfunction and Therapeutic Targeting
2020 · Azin Amin, Nirma D. Perera, et al. · Cells · 104
PDF
Excessive release of inorganic polyphosphate by ALS/FTD astrocytes causes non-cell-autonomous toxicity to motoneurons
2022 · Cristian Arredondo, Carolina Cefaliello, et al. · Neuron · 91
Microglial ferroptotic stress causes non-cell autonomous neuronal death
2024 · Jeffrey R. Liddell, James B.W. Hilton, et al. · Molecular Neurodegeneration · 85
PDF
TDP-43 nuclear loss in FTD/ALS causes widespread alternative polyadenylation changes
2025 · Yi Zeng, Anastasiia Lovchykova, et al. · Nature Neuroscience · 79
PDF
The role of altered protein acetylation in neurodegenerative disease
2023 · Fariha Kabir, Rachel Atkinson, et al. · Frontiers in Aging Neuroscience · 79
PDF
Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord
2022 · Benjamin G Trist, Sian Genoud, et al. · Brain · 78
PDF
Altered skeletal muscle glucose–fatty acid flux in amyotrophic lateral sclerosis
2020 · Frederik J Steyn, Rui Li, et al. · Brain Communications · 71
PDF
Efficacy and safety of CNM-Au8 in amyotrophic lateral sclerosis (RESCUE-ALS study): a phase 2, randomised, double-blind, placebo-controlled trial and open label extension
2023 · Steve Vucic, Parvathi Menon, et al. · EClinicalMedicine · 65
PDF
Aggregation-prone TDP-43 sequesters and drives pathological transitions of free nuclear TDP-43
2023 · Sean S. Keating, Adekunle T. Bademosi, et al. · Cellular and Molecular Life Sciences · 61
Neuronal aging causes mislocalization of splicing proteins and unchecked cellular stress
2025 · Kevin Rhine, Rachel Li, et al. · Nature Neuroscience · 60
The role of lipids in the central nervous system and their pathological implications in amyotrophic lateral sclerosis
2020 · T.J. Tracey, S.E. Kirk, et al. · Seminars in Cell and Developmental Biology · 59
Study protocol of RESCUE-ALS: A Phase 2, randomised, double-blind, placebo-controlled study in early symptomatic amyotrophic lateral sclerosis patients to assess bioenergetic catalysis with CNM-Au8 as a mechanism to slow disease progression
2021 · Steve Vucic, Matthew C Kiernan, et al. · BMJ Open · 55
A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic Inflammation
2023 · Nanthini Jayabalan, Bryan Oronsky, et al. · Drugs · 54
PDF
Kynurenine Pathway Metabolites as Biomarkers for Amyotrophic Lateral Sclerosis
2019 · Vanessa X. Tan, Gilles J. Guillemin · Frontiers in Neuroscience · 54
PDF
Works count: 277
Citation count: 6,205
H-index: 40
I10-index: 110
2-year mean citedness: 8.25
Awards count: 34
Year
Topic
Type